Infectious disease risk of cadaveric tissue donors who used non-injected illicit drugs

Cell and Tissue Banking

Volumn 6, Issue 4, 2005, Pages 249-253

  Gocke, David J ^a   Silvay, Linda ^a  

^a Musculoskeletal Transplant Foundation   (United States)

Author keywords

Allograft safety; Hepatitis C virus transmission; Hepatitus B virus transmission; HIV transmission; Non injection drug use; Tissue donation

Indexed keywords

AMPHETAMINE; CANNABIS; COCAINE; DIAMORPHINE; ILLICIT DRUG; OPIATE;

ARTICLE; BLOOD; BLOOD TRANSFUSION; CADAVER DONOR; CORRELATION ANALYSIS; DISEASE MARKER; DRUG ABUSE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; INFECTION RISK; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; SYPHILIS; TATTOO;

BIOLOGICAL MARKERS; CADAVER; CASE-CONTROL STUDIES; COMMUNICABLE DISEASES; HIV SEROPOSITIVITY; HUMANS; RISK FACTORS; STREET DRUGS; TISSUE DONORS;

EID: 29444458823     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-005-0337-y     Document Type: Article

References (19)

1. American Association of Tissue Banks. 2002. Standards for tissue banking. accessed on 4/6/2005 at http://www.aatb.org.
2. American Association of Tissue Banks and Brubaker S. 2005. Personal communication.
3. Centers for Disease Control Surveillance Summaries, Youth Risk Behavior Survey - United States 1999. (2000). MMWR49(SS5): 1-94.
4. Centers for Disease Control. 2002 Update: Allograft-associated bacterial infections - United States MMWR 51 207-210
5. Centers for Disease Control 2003 Update: Invasive streptococcus pyogenes after allograft implantation - Colorado MMWR 52 48 1173-1176
6. Centers for Disease Control. 2003 Hepatitis C virus transmission from an antibody-negative organ and tissue donor - United States MMWR 13 273-276
7. K.D. Chergwin 1999 Incidence and risk factors for heterosexual acquired HIV in an inner city cohort of women J. AIDS Human Retroviruses 20 295-299
8. E.U. Conrad 1995 Transmission of hepatitis C virus by tissue transplantation J. Bone Joint Surg. Am. 77 214-224 7844127 1:STN:280:ByqC2cnltFA%3D
9. C. Conry-Cantilena 1996 Routes of infection, viremia and liver disease in blood donors found to have Hepatitis C infection N Engl. J. Med. 334 1691-1696 10.1056/NEJM199606273342602 8637513 1:STN:280:BymB2c%2Flt10%3D
10. T. Eastlund 2003. Infectious Disease Transmission through Tissue Transplantation, Advances in Tissue Banking. Vol. 7. World Scientific Publishing Co.
11. H.H. Harsch 2000 Hepatitis C infection in cocaine users - a silent epidemic Commun. Ment. Health J. 36 225-233 1:STN:280:DC%2BD3M%2FksFGhtw%3D%3D
12. Y.I. Hser 1999 Cocaine use and high risk sexual behavior among STD clinic patients Sex Transm Dis. 26 82-86 10029980 1:STN:280:DyaK1M7lsVanug%3D%3D
13. National Institutes of Health Consensus Statement 1998 Hepatology 26 3 suppl 1 2s-10s
14. National Institute on Drug Abuse Research Report Series - Cocaine abuse addiction. accesses on 4/6/2005 at http://www.nida.nih.gov/ ResearchReports/Cocaine/cocaine2.html.
15. G. Quaglio 2003 Factors associated with Hepatitis C virus infection in injection and non-injection drug users in Italy Clin. Infect. Dis. 37 33-40 10.1086/375566 12830406
16. K.A. Page-Shafer 2002 Hepatitis C infection in young, low income women: role of sexually transmitted infection as a potential cofactor for Hepatitis C infection Am. J. Pub. Health 92 670-676 11919070
17. J. Samet 1999 HIV testing in drug abusers Am. J. Drug Alcohol Abuse 25 269-280 10.1081/ADA-100101860 10395160 1:STN:280:DyaK1MzitFSrsQ%3D%3D
18. R.J. Simonds 1992 Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor N. Eng. J. Med. 326 726-732 1:STN:280:By2C2cbmtFM%3D
19. United States Food and Drug Administration. 2004. Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products. final rule - 5/25/2004 accessed on 4/6/2005 at http://www.fda.gov/cber/tissue/docs.htm.